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3. Lws. Mimuri 
This study war designed to delermine in patients with unstable 
angina whelher specific elrctrcxardiographic abnormalities asso- 
ciated with irchemis, the presence of coronary lesions consistenl 
with thromhosia on angiography or the presence of recurrent 
&hernia reflects increases in lhmmbin activity as maniierted by 
iocreased plasma cancentratloas of Rhrlnopeptlde A. 
The concentration of fibrinopeptide A in plasma was increased 
to 6.7 2 3. I M for lho group as a whole (II = 29). Increares were 
greater in ihe 17 patients who exhibited reversible ST segment 
shills LIO.2 t 5.2 n&f) than in the 12 patients exhibiting reversible 
T wwe abnormalities alone (I.6 * 0.2 nM) ro c OJILI. Nine af Ihe 
17 patients with reversible ST segment~shifts who underwent 
A critical determinant of the progression from stable to 
unstable coronary artery disease is the development of 
thrombosis on rupiured or fissured aiherosclerotic plaques 
(1.2). The progression of coronary thrombosis IO total oc- 
clusion in patienta wilh Q wave myocardial infarction (3) as 
opposed to the subtotal occlusion in those with unstable 
angina or non-Q wave infarction (1.3-7) may depend on the 
intensity of activity of the procoagulant factors that promote 
clol formation and the extent to which physiologic fibrin- 
olytic activity induces cl01 lysis. Despite the lack of total 
coronary thrombotic occlusion in patients with unstable 
angina or non-Q wave infarction. inhibition of thrombosis or 
induction of fibrinolysis with pharmacologic agenrs has been 
shown to decrease the incidence of subsequent myocardial 
infarction (S-13). Alihough it is likely that only patients with 
ongoing coronary thrombosis will benefit from antithrom- 
botic or fibrinolytic interventions, methods to identify such 
palicnts have nol yet been developed. 
Although coronary thrombi and atherosclerotic plaques 
From Ihe Carduvarcrdar Diwon. Washmgm Uweruty School of 
Mcdw~o. Washington Uoiversily Medical Center. St. Loua. hlisrouri. This 
study war rupponed m part by SCOR in Coromry and Vasculrr Hurl 
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coronary engiography had lesions with morphologic charactcris- 
tics consistent with atherosclerotic plaque complicated by throm- 
bosjscompaced with only 2 019 patients with T wave changes only 
(p < 0.05). Plasma cancentralions of fibrinoplptide A were 
markedly elevated in 7 ofthe I1 patients in whom complex kskmr 
were noted on anglograpblc examination. 
Thus, the occurrence of reversible ST segment shills ideniifies 
a group of palients with uesiable engine in whom ongoing 
thrombosis is likely and who may be particularly likely CO hewfit 
from antitbrombalic therapy. 
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complicated by thrombosis defined angiographically have 
been described in many patients with unstableangina( the 
presence of a thrombotic lesion does not always imply 
ongoing thrombin activity. In addition. transient thrombosis 
followed by fibrinolysis may not be detected on m&graphic 
examination. We and others (14) have characterized procc- 
agulant activity in patients with ischemic heart disease with 
plasma concentrations of fibrinopeptide A. a peptide re- 
leased by lhrombin during the formation of fibrin. which has 
a short half-life in plasma (3 to 5 min). In pmients with acute 
Q wave myocardial infarction. plasma concentrations of 
fibrinopeptide A are highly elevated early but no1 late after 
the onset of symptoms. a finding consistent with the occur- 
rence of acute coronary thrombosis (IS). Less marked 
increases in the concentration of fibrinopeptide A alsooccur 
in patients with unstable angina; however, the relation of 
such increases IO clinical manifestalions of ischemia has not 
been defined (16-18). 
The present study was designed to determine the relation 
of specific clinical criteria. including electmcdldiographic 
@CC) abnormalides associated with irchemia, angiographic 
evidence of coronary thrombosis and the incidence of recur- 
rent &hernia. to increases in the concentration of plasma 
fibrinopeptide A. Concentrations of cross-linked fibrin deg- 
radalion products, a marker offibrinolytic activity 1191. were 
also measured to take into account previous dam (ZIJ) 
suggesting that an increased concentration reflects coronary 
thrombosis and to determine whether clinical events might 
be related to The balznce between procoagulan~ and fibrin- 
olytic aclivity. 
Methods 
Patient selection. Patients were studied only if the! hdd 
either new onset of ischemic chest discomfon occurring at 
rest or a patlern of accelerating ischemic chest discomfort 
and ECG changes consistent with Ischemia. Such ECG 
changes were defined as ebthcr I) transient ST hegmcnt 
elevation or depression of 20. I mV in two contiguous lead\. 
or 2) T wave invcrrion or “preudonormalimtion” in two 
contiguous leads that occurred during an episude uf chest 
discomfort and reverted to normal or to the pattern on a 
previous ECG. Patients were excluded of they had had a 
myocardial infarction documented by increases in the cre- 
atine kinase [CK)-MB isoenzyme concentrations within the 
past 21 days, developed increased CK-MB concenwatiom 
within 24 h of admission. were receiving immvcnous hepann. 
bad a known malignancy. had a major illnw known to be 
associated with abnormalities of platelet function or coagula- 
tion or had evidence of venous or arterial thromboembolic 
disease. The study was approved by the Human Studies 
Committee at Washington University School of Medicine. 
ECC analysis. Eleclrocnrdiogmmi were obtained in the 
standard 12-leadconfiguration and were interpreted mdepen- 
dently by two experienced electrocardiographer1. Parienlz 
were categorized as having predominantly ST segment 
abnormalities during ischemia if they manifested either I) 
~0. I mV of ST segment depresvon. or 2) elevation in two 
contiguous leads during the ischemic episode wth ruhw 
quent reversion to normal or to a baseline defined by a 
previous ECG. Parents were categorized as having predom- 
inantly T wave changes if there was T wave invewon or 
“pseudonormalization” during the episode of iwhema 
symptoms with subsequent reversion to normal or to d 
baseline defined by a previous ECG. 
Blood sampling procedure. Blood samples were acquired 
from eligible patients as soon a, possible after admibhion to 
the cardiac care unit at Barnes Hospital. Samples were 
obtained before patients were Riven aspirin or hepann. Only 
IWO patients reported taking aspirin at home before admir- 
sion. All blood samples were obtained by specially trained 
technicians using a meticulou> venipuncture technique. 
Blood was drawn into collection tubes cuntaininp cthylene- 
diaminetetraacetic acid IEDTAI. aprorinin and o-phcnyl- 
alanyl-L-prolyl-L-arglnine chloromerhylkerone (PPACK. 
Calbiocheml. a potent thrombin inhibitor. Blood wmple\ 
were cooled rapidly to J”C and centrifuged ,I I.502 $ for 
30 min. Plasma was teparnted nnd frozen at -WC for 524 h 
and stored at -7OT until it was assayed. 
Asw for fibrinowtllide A. Havna samoles were treated 
I . 
with bcntoniir abwrpliun IO remove truss-reacting librin- 
ogen before assay of fihrmopeptidc .4 121 I. Flbrinopeplldc A 
was measured by radiuimmunoaw~y uith an anrihody oh- 
tamed from Banck Sangtek tDwr/cnhach. Gcrmanyl. In our 
laborwry. the detectability of this awy is I n,M and rhe 
upper hmlt of normal IS 1.j r&f. Interassay vanahihry i? 1.7 
10.X 1151. 
Assav of cross-linked fibrin degradation producti. COP 
cenrr~rinnc of cmss-hnked fihnn degradahon products m 
playma ~+ere derernnned by enzyme-kinked tmmunosorbent 
assay (ELlSA) wth specific monoclunal antibodies from 
American Diagnorrica BF previously described (12.23). The 
monoclondl .mribody. which is specific fwcruss-linked fibrin 
D re:ions ~munoclonal antibody 3861. w&s supplied pre- 
coated on a 96.well micrutitrr plate. An aliquot of the plasma 
sample wb dduted at least 15. added to the plate and 
incubated for I h. The plate was then washed twice and a 
second antibody specific for an ep!tope m the D @on of 
hbrin or librinugcn (conjugated to horseradish peroxidasel 
ws added. After a 1.h incubation. rhe plate was washed and 
whatrate (2.drlno-di-13.ethyl-henzothiarolinel sulphinate) 
IATBS. Kirbgaard Perry) was added. hbsorbancc was dc- 
wrmined wirh an automatic microtiter plate reader with the 
use uf a commercial analysis program ~Biorad Laboratoriesl. 
Interpretation ol coronary nngiograms. Coronary ongio- 
grams uere reviewed (according to the cri~eriza proposed by 
Ambrose et al. 141) by two of Ihe investigators who are 
c\pericnccd iwasive cardiologists. On the &is of these 
crMi& le,ion\ in the Ischemia-r&led vewel. as determined 
by ECG abnormahties. were class&d as eccenrric. concew 
1r1-z or manifeelting multiple irregularities. Eccen~nc ierionc 
wre fnrther wbdivided into type I lesions. in which the 
surface and burders of the lesion were smooth. and type II 
lecions. in which there were surface irreglariries or over- 
hanging edge? present. Multiple lrregulanties were consid- 
ered to be present when there were multiple lesions wth 
\urtace irregulariries. Clnssificarion of lesions based on these 
morphologtc wteria was determined by the appearance in at 
lea\1 two yiws. lntracoronary thrombus WBE defined as a 
filling dcfcct wrrounded by contrasi medium in two or more 
view Coronary angiograms were interpreted by each inves- 
tlgator Independently. When discrepancies in interpretation 
occurred. thu angiogmms were apin reviewed by both 
investig.lton and a consen%~s was reached. 
Statistical analysis. Dana are expressed as mean valuer * 
SEX Because values for Cbrinopeptide A concentration arc 
skewed. a log transformation was used to normalize the data 
bcforc analyw Comparisons between groups were made 
with an unpaired two-tailed I text for continuous data or with 
a chi-square lest with continuity corrcclion for discrete 
vanables. Differences between groups were considered zig- 
nificant 81 p < 0.05. 
Results 
ECG findings (Table I). Twenty-nine consccutwc pa- 
ticnt9 tilth unstable ischemia and reversible ECG changes 
here studied. The mean age of the paticnrs was 64.8 2 ?.I 
gears. Rrvertlble ST segment or T wave changes we ob 
served m precordial leads (V, to V,) in I2 patients. antemlal- 
ml arecordial leads IV. to !‘,I in 3. anterolateral leads IV,. V.. 
1. a;L) in lOand inferdposte&~~ leads (II. 111. aVF. V,. V,t g 
4. Seventeen (59%) of the 29 patients exhibited rcvcrsible ST 
segment depression tn = 151 or ST segment elevation (n = 21 in 
association with ischemic symptoms; the other I2 (4l%lexhib- 
ited reversible T wave abnormalities. 
Plasma levels of fibrinopepiide A and fibrin degradation 
products. Blood samples were obtained a mean of 8.8 2 
1.2 h after the last episode of ischemic symptoms. For the 
group as a whole. the concentration of tibrinopeptide A in 
plasma was increased to a mean of 6.7 2 3.1 nM. The 
concentration of crosshnked fibrin degradation products war 
increased to >300 ndml. the upperrange of normal in plasma. 
in only I of the 27 patients in whom it was measured; in 21 
patients, plasma concentrations of cross-linked fibrin degrada- 
tion products were below the lower limit of deteciability 
cc78 ngrml). 
Relation of concentrations of fibrinopeptide A to ECC 
abnormalities. Concentrations of tibrinopeptide A in plasma 
were significantly higher in the 17 patients who exhibited 
reversible ST segment shifts than in the I2 patients who had 
only ischemic T wave abnormalities (IO.2 i 5.2 compared 
with 1.6 ? 0.2 nM; p < 0.01) (Fig. It. The concentration of 
tibrinopcptide A in plasma was increased in all but 2 of the 
patients with ST segment elevation or depression (normal 5 
1.5 nM) compared with modest elevations in only 4 of the 12 
patients with ischemic T wave changes. 
Recwrenr CIWI discornfori occurred in IO of the 17 patients 
with ST segment shifts compared with only 2 of the I2 patients 
with T wave abnormalities tp < 0.05). All patients with 
recurrent chest pain had elevation of fibrinopeptide A; how- 
ever. the extent of the elevation in the I2 patients with 
recurrent chest pain (8.0 2 5.5 nM) was not statistically 
different from that in the 17 pattents without recurrent chest 
pain (5.1 ? 1.8 r&0 (p = 0.45). The increase in plasma 
concentration of fibrinopeptide A was greater in samples ob- 
tained early after the ottsct of symptotns than in those obtained 
later (Fig. 2). However, elevations of tibrinopeptide A were 
substantially greater in the patients with ST segment changes 
than in those with T wave changes. even when the interval 
from the onset of symptoms was considered. 
Coronary sngiogrsphic correlates. Coronary at&grams 
were obtained for clinical indications in 21 of the 29 patients. 
In I3 patients, angiographh examination was performed on 
an emergency basis (within 48 h of admission) and in 8, 
Figure 1. Comparison of plasma concentrations of fibrinopeptide A 
IFPAl in ZPtmtients with unstable angina: 17 patients who exhibited 
ST segment shift5 on the admission electmcardiagram (ECG) IbLack 
circles1 and I2 pauentr with T wave changes only on the admission 
ECG (gray drcles~. Concentrations al fibrinopeptide A in plasma of 
healthy nonhospitalized volunteers InI) are < 1.5 nM. Fibrinopeptide 
A was elevated to a significantly greater extent in patients who 
exhibited ST segment shifts than in those with T WBYC changes (p < 
0.01). 
between 3 and 8 days after admission. Concentrations of 
brinopeptide A were markedly elevated in 7 of I I patients in 
whom the angiographic morphology was indicative of athem- 
sclerotic lesion complicated by thrombus (Fig. 3). All seven 
patients exhibited reversible ST segment shifts on admission. 
Nine of the 17 patients with reversible ST segment shifts who 
underwent angiography had complex lesions catqxred with 
only 2 of 9 with T wave changes (p = O.OS). Although patients 
with complex lesions tended to have recurrentischemia (7 of I I 
compared with 2 of 10 with other types of lesions). this relation 
was nol statistically significant (p = 0.12). Only one patient was 
found to have intraluminal filling consistent with coronary 
thrombus; the concentration of fibrinopeptide A was not ele- 
vated in the blood sample obtained from this patient an 
admissionand he exhibited only T wave changes inassociation 
with ischemic symptoms. The concentration of fibtinopeptide 
A was not elevated in the two patients with normal coronary 
arteriogams. Modest elevations of Abrinopeptide A were 
present in two patients with athemsclemtic comnary artery 
disease in the absence of significant stenosis t-=X% cross- 
sectional htminal diameter). 
Discussion 
Patients who present with criteria for unstable angina 
may have diverse under!ying coronary artery disease and 
thus may respond ditTerently to pharmacologic interventions 
Figure 2. Relation 01 plasma concenlr~tian> ,JC Rbrinopeptidc 4 
(WA) to the interval between the onw ofhymptomr and the trne at 
which the sample WPE drawn. Concentrations ufhbrinopeptide .4 m 
pauents with ST segment shifts on the ekctrocardiottr~m IECG) are 
shown by bbxb circles. Cny circles indicare eoncentranons m 
patients with T wave changes only. A trend toward greater eleva- 
lions in the concentration of tibrinopcptide A in samples obluned 
wee consistently high& in’patienrs with ST segment shifts Ihsn in 
those with T wave changes only on the admivian ECG 
(24). Some but not all patients with unsiable angina harbor 
coronary thrombus that appears to play an important role in 
the development of ischemic symptoms and progression IU 
myocardial infarction. Our data suggest that in patients with 
unstable angina, ST segment shifts during ischemia are 
associated with increased thrombin activity. These resuhr 
show that the increased risk of developing myocardad in- 
farction observed in patients with ST scgmcnt dcprcssion 
during episodes of iscbemia may be due to the presence of 
active thrombosis. Thus, patients with labile ST segment 
shifts may benefit from treatment with antithrombotic 
agents. which have been shown in some studies 18-12) to 
improve the prognosis of patients with unstable angina. 
Coronary thrombosis in patients with unstable angina. 
This appears IO be a dynamic process. judging from recent 
and old layers of fibrin evident on histopathologic examina- 
tion ofatherosclcrotic Ics~ocs in patients who die of ischemrc 
hean disease II). lt is likely that thrombosis develops when 
the subendothelial procoagulant surface of the atherosclc- 
rotic plaque is exposed to blood. but the factors that deter- 
mine the extent of thrombosis hape not been well d&cd. 
Our dam and those of others I&IYI document increased 
thmmbin activity as indicated by increased concentrations 
of hbrinopepude A in patients with unstable angina. perhaps 
reflecting the procoagulant properties of atherosclcrouc le- 
sions. The elevations of fibrmopeptide A appear to be of a 
are rho\vn by black circles. Concentrations tn paucnrs snh T ua\‘e 
changes only xc indicated hy gram cirrl~. Conccntr;ltiow offibbnn- 
opeplide :\ were higher in patients with ST reernent shifts and the 
majonty of such padents exhibited complex lesions an coronary 
angiography. 
lesser magnitude than those measured early after the onset 
of acute transmural myocardral infarclion. suggesting that 
the procoagulant stimulus may not be as great m patients 
wiih unstable angina compared with th?r leading to coronary 
occlusmn III patients with acute myocardial infarction 115). 
These dais dre consistent with results of studies (8.1 II 
demonstrating a decrease in the rate ofmyucardial infarction 
and mortalny m patients with unstable angina treated with 
heparin. 
Fibrinolytic activily in patients with coronary artery dis- 
ease. The possibility that increased intrinsic hbrittolytic ac- 
tivtty prevents total coronary occlusion in patients with 
unstable angma is not supported by our finding of normal 
plasma concentrations of cross-linked fibrin degradation 
products. This result. similar to that we previously reported 
C 191 in patients with uncomplicated acute myocardial infarc- 
tion. suggests that fibrinolytic activity is limited in patients 
with coronary artery disease. This finding is consistent with 
the observation of increased plasma activity of plasmjnogen 
activator inhIbitor- in survivors of acute myocardial infarc- 
lion. which would be expected IO hmn physmlogic Rbnn- 
olytlc actrvity (25). The lack of significant intrinsic fibrin- 
olytic activity suggests that patients with unstable angina in 
whum coronary thrombosis is present may benefit from 
pharmacologic plasminogen activation to induce clot 14s. 
Although incrcascs in cross-linked Rbrin degradation prod- 
ucts were reported by Kruskal ct al. (?Ol in patients with 
unstable angina. the speuficily LIT their polyclonal anllbody- 
based assa!: li~or crowlinked fibrin as opposed IO noncrow 
linked librin UT fibrinogen was not well characterized. The 
lack of clewlion of cross-linked fibrin degradalion pwJucfs 
in our study p&ably reflects fhe greater specificity of the 
monoclonal antibody-based assay we used. 
Deteciion alcoronary thrombu. Delining ,he occurrence 
of coronary thrombwis in individual paGents remains dif- 
ficull. Although angiographic crilerla appear useful in de- 
fining the presence of lesions complicated by fissuring and 
thrombosis (4. the morphologic characteristics of such 
lesion5 may remain abnormal even after thrombin activity 
has ccascd. Accordingly. the prcrcncc of a complex lesion 
may not bc indicative ofongoing lhrorrbosis. The inabilily tu 
predicl significanl improvement in the degree of lesion 
sfenoaia or morphology in patients given intracoronary fi- 
brinolytic agent\ ~~ggesrs thal angiographic criteria cannot 
distinguish rccen~ coronary thrombi susceptible IO plasmin 
proteolysis from older CIOIS. which are resistant 10 ly4r 
(26-29). Biochemtcal criteria such nz increased plasma con- 
ccntralions of fibrinopeptide A. although sensitive. will not 
dewct Ihc procnce of coronary thrombosis when thrombin 
actiwty 1s only transiently increased because lhe plasma 
half-life of this marker is only 3 to 5 min. This short haWife 
may account fur the greater elevations of fibrinopeptide A in 
plasma samples obtained early after the onset of symptoms. 
Clinical implicalions. Previous results (30) have shown 
that patients with symptoms associated with unstable isch- 
emId who manifest reversible ST segment shifts during 
episodes of whernu~ are I grealcst risk for the evolulion uf 
acute myocardial inhrcliun. In addition. the presence of ST 
segmenl shift on the admirsion ECG or during Hohcr ECG 
monitoring in paiients with unstable angina is associated 
wilh an unfavorable outcome and a higher incidence of 
muhivessel coronary disease 13 I). Our data suggest that such 
patients are hkely IO have increase> in fibrinopeptide A 
consistent w,th ongoing thrombin activity. most likely due to 
aclive coronary thrombosis. Thus. clinical criieria such as 
:ccxrPnt chesl pain and reversible ST segment shift during 
episodes of ischemia appear to identify palicnts more likely 
to have onjioing coronary thromhosir. Although others may 
benefit, this subgroup of patients appears to be particularly 
suirablc for treatment with anticoagulant or fihrinolylic 
apent5. 
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